T1	B-Protein	0	3	Bcl	Bcl	B-NP	NN	B-protein	5	SUB	B-protein
T1	I-Protein	3	4	-	-	B-NP	HYPH	I-protein	1	P	I-protein
T1	I-Protein	4	5	2	2	I-NP	CD	I-protein	1	NMOD	I-protein
O	O	5	6	-	-	I-NP	HYPH	O	1	P	O
O	O	6	14	mediated	mediate	I-NP	VBN	O	7	NMOD	O
O	O	15	19	drug	drug	I-NP	NN	O	7	NMOD	O
O	O	20	30	resistance	resistance	I-NP	NN	O	9	NMOD	O
O	O	30	31	:	:	O	:	O	7	P	O
O	O	32	42	inhibition	inhibition	B-NP	NN	O	0	ROOT	O
O	O	43	45	of	of	B-PP	IN	O	9	NMOD	O
O	O	46	55	apoptosis	apoptosis	B-NP	NN	O	10	PMOD	O
O	O	56	58	by	by	B-PP	IN	O	9	NMOD	O
O	O	59	67	blocking	block	B-VP	VBG	O	12	PMOD	O
O	O	68	75	nuclear	nuclear	B-NP	JJ	O	27	NMOD	O
O	O	76	82	factor	factor	I-NP	NN	O	27	NMOD	O
O	O	83	85	of	of	B-PP	IN	O	15	NMOD	O
O	O	86	95	activated	activate	B-NP	VBN	O	19	NMOD	O
O	O	96	97	T	T	I-NP	NN	O	19	NMOD	O
O	O	98	109	lymphocytes	lymphocyte	I-NP	NNS	O	16	PMOD	O
O	O	110	111	(	(	O	(	O	22	DEP	O
O	O	111	115	NFAT	NFAT	B-NP	NN	B-protein	22	DEP	B-protein
O	O	115	116	)	)	O	)	O	19	NMOD	O
O	O	116	117	-	-	B-NP	HYPH	O	15	P	O
O	O	117	124	induced	induce	I-NP	VBN	O	27	NMOD	O
T2	B-Protein	125	128	Fas	Fas	I-NP	NN	B-protein	27	NMOD	B-protein
T2	I-Protein	129	135	ligand	ligand	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	136	149	transcription	transcription	I-NP	NN	O	13	OBJ	O
O	O	149	150	.	.	O	.	O	9	P	O

T3	B-Protein	152	155	Bcl	Bcl	B-NP	NN	B-protein	4	SUB	B-protein
T3	I-Protein	155	156	-	-	O	HYPH	I-protein	1	NMOD	I-protein
T3	I-Protein	156	157	2	2	B-NP	CD	I-protein	1	NMOD	I-protein
O	O	158	166	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	O
O	O	167	176	apoptosis	apoptosis	B-NP	NN	O	4	OBJ	O
O	O	177	184	induced	induce	B-VP	VBN	O	5	NMOD	O
O	O	185	187	by	by	B-PP	IN	O	6	VMOD	O
O	O	188	189	a	a	B-NP	DT	O	9	NMOD	O
O	O	190	197	variety	variety	I-NP	NN	O	7	PMOD	O
O	O	198	200	of	of	B-PP	IN	O	9	NMOD	O
O	O	201	208	stimuli	stimulus	B-NP	NNS	O	10	PMOD	O
O	O	208	209	,	,	O	,	O	11	P	O
O	O	210	219	including	include	B-PP	VBG	O	11	NMOD	O
O	O	220	232	chemotherapy	chemotherapy	B-NP	NN	O	15	NMOD	O
O	O	233	238	drugs	drug	I-NP	NNS	O	17	NMOD	O
O	O	239	242	and	and	I-NP	CC	O	17	NMOD	O
O	O	243	258	glucocorticoids	glucocorticoid	I-NP	NNS	O	13	PMOD	O
O	O	258	259	.	.	O	.	O	4	P	O

O	O	260	262	It	It	B-NP	PRP	O	2	SUB	O
O	O	263	265	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	266	275	generally	generally	I-VP	RB	O	2	VMOD	O
O	O	276	284	accepted	accept	I-VP	VBN	O	2	VC	O
O	O	285	289	that	that	B-SBAR	IN	O	4	VMOD	O
T4	B-Protein	290	293	Bcl	Bcl	B-NP	NN	B-protein	9	SUB	B-protein
T4	I-Protein	293	294	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T4	I-Protein	294	295	2	2	I-NP	CD	I-protein	6	NMOD	I-protein
O	O	296	302	exerts	exert	B-VP	VBZ	O	5	SBAR	O
O	O	303	306	its	its	B-NP	PRP$	O	12	NMOD	O
O	O	307	320	antiapoptotic	antiapoptotic	I-NP	JJ	O	12	NMOD	O
O	O	321	328	effects	effect	I-NP	NNS	O	9	OBJ	O
O	O	329	335	mainly	mainly	B-ADVP	RB	O	14	PMOD	O
O	O	336	338	by	by	B-PP	IN	O	9	VMOD	O
O	O	339	349	dimerizing	dimerize	B-VP	VBG	O	14	PMOD	O
O	O	350	354	with	with	B-PP	IN	O	15	VMOD	O
O	O	355	367	proapoptotic	proapoptotic	B-NP	JJ	O	18	NMOD	O
O	O	368	375	members	member	I-NP	NNS	O	16	PMOD	O
O	O	376	378	of	of	B-PP	IN	O	18	NMOD	O
O	O	379	382	the	the	B-NP	DT	O	24	NMOD	O
O	O	383	386	Bcl	Bcl	I-NP	NN	B-protein	24	NMOD	B-protein
O	O	386	387	-	-	O	HYPH	I-protein	24	NMOD	I-protein
O	O	387	388	2	2	B-NP	CD	I-protein	24	NMOD	I-protein
O	O	389	395	family	family	I-NP	NN	I-protein	19	PMOD	I-protein
O	O	396	400	such	such	B-PP	JJ	O	26	PMOD	O
O	O	401	403	as	as	I-PP	IN	O	18	NMOD	O
T5	B-Protein	404	407	Bax	Bax	B-NP	NN	B-protein	29	NMOD	B-protein
O	O	408	411	and	and	I-NP	CC	O	29	NMOD	O
T6	B-Protein	412	415	Bad	Bad	I-NP	NN	B-protein	26	PMOD	B-protein
O	O	415	416	.	.	O	.	O	2	P	O

O	O	417	424	However	However	B-ADVP	RB	O	9	VMOD	O
O	O	424	425	,	,	O	,	O	9	P	O
O	O	426	429	the	the	B-NP	DT	O	4	NMOD	O
O	O	430	439	mechanism	mechanism	I-NP	NN	O	9	SUB	O
O	O	440	442	of	of	B-PP	IN	O	4	NMOD	O
O	O	443	446	the	the	B-NP	DT	O	8	NMOD	O
O	O	447	460	antiapoptotic	antiapoptotic	I-NP	JJ	O	8	NMOD	O
O	O	461	468	effects	effect	I-NP	NNS	O	5	PMOD	O
O	O	469	471	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	472	479	unclear	unclear	B-ADJP	JJ	O	9	PRD	O
O	O	479	480	.	.	O	.	O	9	P	O

O	O	481	491	Paclitaxel	Paclitaxel	B-NP	NN	O	4	NMOD	O
O	O	492	495	and	and	O	CC	O	4	NMOD	O
O	O	496	501	other	other	B-NP	JJ	O	4	NMOD	O
O	O	502	507	drugs	drug	I-NP	NNS	O	9	SUB	O
O	O	508	512	that	that	B-NP	WDT	O	4	NMOD	O
O	O	513	520	disturb	disturb	B-VP	VBP	O	5	SBAR	O
T24	B-Entity	521	532	microtubule	microtubule	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	533	541	dynamics	dynamic	I-NP	NNS	O	6	OBJ	O
O	O	542	546	kill	kill	B-VP	VBP	O	27	VMOD	O
O	O	547	552	cells	cell	B-NP	NNS	O	9	OBJ	O
O	O	553	555	in	in	B-PP	IN	O	9	VMOD	O
O	O	556	557	a	a	B-NP	DT	O	16	NMOD	O
T7	B-Protein	558	561	Fas	Fas	I-NP	NN	B-protein	16	NMOD	B-protein
O	O	561	562	/	/	O	SYM	O	16	P	O
T8	B-Protein	562	565	Fas	Fas	B-NP	NN	B-protein	16	NMOD	B-protein
T8	I-Protein	566	572	ligand	ligand	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	573	574	(	(	O	(	O	19	DEP	O
T9	B-Protein	574	578	FasL	FasL	B-NP	NN	B-protein	19	DEP	B-protein
O	O	578	579	)	)	O	)	O	16	NMOD	O
O	O	579	580	-	-	B-NP	HYPH	O	22	P	O
O	O	580	589	dependent	dependent	I-NP	JJ	O	22	NMOD	O
O	O	590	596	manner	manner	I-NP	NN	O	11	PMOD	O
O	O	596	597	;	;	O	:	O	27	P	O
O	O	598	606	antibody	antibody	B-NP	NN	O	27	SUB	O
O	O	607	609	to	to	B-PP	TO	O	24	NMOD	O
T10	B-Protein	610	614	FasL	FasL	B-NP	NN	B-protein	25	PMOD	B-protein
O	O	615	623	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	O
O	O	624	634	paclitaxel	paclitaxel	B-NP	NN	O	31	NMOD	O
O	O	634	635	-	-	B-NP	HYPH	O	28	P	O
O	O	635	642	induced	induce	I-NP	VBN	O	31	NMOD	O
O	O	643	652	apoptosis	apoptosis	I-NP	NN	O	27	OBJ	O
O	O	652	653	.	.	O	.	O	27	P	O

O	O	654	656	We	We	B-NP	PRP	O	2	SUB	O
O	O	657	661	have	have	B-VP	VBP	O	0	ROOT	O
O	O	662	667	found	find	I-VP	VBN	O	2	VC	O
O	O	668	672	that	that	B-SBAR	IN	O	3	VMOD	O
T11	B-Protein	673	676	Bcl	Bcl	B-NP	NN	B-protein	8	NMOD	B-protein
T11	I-Protein	676	677	-	-	B-NP	HYPH	I-protein	5	NMOD	I-protein
T11	I-Protein	677	678	2	2	I-NP	CD	I-protein	8	NMOD	I-protein
O	O	679	693	overexpression	overexpression	I-NP	NN	O	9	SUB	O
O	O	694	699	leads	lead	B-VP	VBZ	O	4	SBAR	O
O	O	700	702	to	to	B-PP	TO	O	9	VMOD	O
O	O	703	706	the	the	B-NP	DT	O	12	NMOD	O
O	O	707	717	prevention	prevention	I-NP	NN	O	10	PMOD	O
O	O	718	720	of	of	B-PP	IN	O	12	NMOD	O
O	O	721	733	chemotherapy	chemotherapy	B-NP	NN	O	13	PMOD	O
O	O	734	735	(	(	O	(	O	17	DEP	O
O	O	735	745	paclitaxel	paclitaxel	B-NP	NN	O	17	DEP	O
O	O	745	746	)	)	O	)	O	14	NMOD	O
O	O	746	747	-	-	O	HYPH	O	14	P	O
O	O	747	754	induced	induce	B-NP	VBN	O	20	NMOD	O
O	O	755	765	expression	expression	I-NP	NN	O	18	OBJ	O
O	O	766	768	of	of	B-PP	IN	O	20	NMOD	O
T12	B-Protein	769	773	FasL	FasL	B-NP	NN	B-protein	21	PMOD	B-protein
O	O	774	777	and	and	O	CC	O	9	VMOD	O
O	O	778	784	blocks	block	B-VP	VBZ	O	9	VMOD	O
O	O	785	795	paclitaxel	paclitaxel	B-NP	NN	O	28	NMOD	O
O	O	795	796	-	-	B-NP	HYPH	O	25	P	O
O	O	796	803	induced	induce	I-NP	VBN	O	28	NMOD	O
O	O	804	813	apoptosis	apoptosis	I-NP	NN	O	24	OBJ	O
O	O	813	814	.	.	O	.	O	2	P	O

O	O	815	818	The	The	B-NP	DT	O	2	NMOD	O
O	O	819	828	mechanism	mechanism	I-NP	NN	O	6	SUB	O
O	O	829	831	of	of	B-PP	IN	O	2	NMOD	O
O	O	832	836	this	this	B-NP	DT	O	5	NMOD	O
O	O	837	843	effect	effect	I-NP	NN	O	3	PMOD	O
O	O	844	846	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	847	851	that	that	B-SBAR	IN	O	6	PRD	O
T13	B-Protein	852	855	Bcl	Bcl	B-NP	NN	B-protein	11	SUB	B-protein
T13	I-Protein	855	856	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T13	I-Protein	856	857	2	2	I-NP	CD	I-protein	8	NMOD	I-protein
O	O	858	866	prevents	prevent	B-VP	VBZ	O	7	SBAR	O
O	O	867	870	the	the	B-NP	DT	O	14	NMOD	O
O	O	871	878	nuclear	nuclear	I-NP	JJ	O	14	NMOD	O
O	O	879	892	translocation	translocation	I-NP	NN	O	11	OBJ	O
O	O	893	895	of	of	B-PP	IN	O	14	NMOD	O
O	O	896	900	NFAT	NFAT	B-NP	NN	B-protein	15	PMOD	B-protein
O	O	901	902	(	(	O	(	O	32	DEP	O
O	O	902	909	nuclear	nuclear	B-NP	JJ	O	19	NMOD	O
O	O	910	916	factor	factor	I-NP	NN	O	23	NMOD	O
O	O	917	919	of	of	B-PP	IN	O	23	NMOD	O
O	O	920	929	activated	activate	B-NP	VBN	O	23	NMOD	O
O	O	930	931	T	T	I-NP	NN	B-cell_type	23	NMOD	B-cell_type
O	O	932	943	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	27	NMOD	I-cell_type
O	O	943	944	,	,	O	,	O	27	P	O
O	O	945	946	a	a	B-NP	DT	O	27	NMOD	O
O	O	947	960	transcription	transcription	I-NP	NN	B-protein	27	NMOD	B-protein
O	O	961	967	factor	factor	I-NP	NN	I-protein	32	DEP	I-protein
O	O	968	977	activated	activate	B-VP	VBN	O	27	NMOD	O
O	O	978	980	by	by	B-PP	IN	O	28	VMOD	O
T25	B-Entity	981	992	microtubule	microtubule	B-NP	NN	B-protein	31	NMOD	B-protein
O	O	993	999	damage	damage	I-NP	NN	O	29	PMOD	O
O	O	999	1000	)	)	O	)	O	16	NMOD	O
O	O	1001	1003	by	by	B-PP	IN	O	11	VMOD	O
O	O	1004	1011	binding	bind	B-VP	VBG	O	33	PMOD	O
O	O	1012	1015	and	and	I-VP	CC	O	34	VMOD	O
O	O	1016	1028	sequestering	sequester	I-VP	VBG	O	34	VMOD	O
O	O	1029	1040	calcineurin	calcineurin	B-NP	NN	B-protein	43	NMOD	B-protein
O	O	1040	1041	,	,	O	,	O	43	P	O
O	O	1042	1043	a	a	B-NP	DT	O	43	NMOD	O
O	O	1044	1051	calcium	calcium	I-NP	NN	B-protein	43	NMOD	B-protein
O	O	1051	1052	-	-	B-NP	HYPH	I-protein	43	NMOD	I-protein
O	O	1052	1061	dependent	dependent	I-NP	JJ	I-protein	43	NMOD	I-protein
O	O	1062	1073	phosphatase	phosphatase	I-NP	NN	I-protein	34	VMOD	I-protein
O	O	1074	1078	that	that	B-NP	WDT	O	43	NMOD	O
O	O	1079	1083	must	must	B-VP	MD	O	44	SBAR	O
O	O	1084	1099	dephosphorylate	dephosphorylate	I-VP	VB	O	45	VC	O
O	O	1100	1104	NFAT	NFAT	B-NP	NN	B-protein	46	OBJ	B-protein
O	O	1105	1107	to	to	B-VP	TO	O	49	VMOD	O
O	O	1108	1112	move	move	I-VP	VB	O	46	VMOD	O
O	O	1113	1115	to	to	B-PP	TO	O	49	VMOD	O
O	O	1116	1119	the	the	B-NP	DT	O	52	NMOD	O
O	O	1120	1127	nucleus	nucleus	I-NP	NN	O	50	PMOD	O
O	O	1127	1128	.	.	O	.	O	6	P	O

O	O	1129	1136	Without	Without	B-PP	IN	O	9	VMOD	O
O	O	1137	1141	NFAT	NFAT	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	1142	1149	nuclear	nuclear	I-NP	JJ	O	4	NMOD	O
O	O	1150	1163	translocation	translocation	I-NP	NN	O	1	PMOD	O
O	O	1163	1164	,	,	O	,	O	9	P	O
O	O	1165	1168	the	the	B-NP	DT	O	8	NMOD	O
T14	B-Protein	1169	1173	FasL	FasL	I-NP	NN	B-DNA	8	NMOD	B-DNA
O	O	1174	1178	gene	gene	I-NP	NN	I-DNA	9	SUB	I-DNA
O	O	1179	1181	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1182	1185	not	not	I-VP	RB	O	9	VMOD	O
O	O	1186	1197	transcribed	transcribe	I-VP	VBN	O	9	VC	O
O	O	1197	1198	.	.	O	.	O	9	P	O

O	O	1199	1203	Thus	Thus	B-ADVP	RB	O	4	VMOD	O
O	O	1203	1204	,	,	O	,	O	4	P	O
O	O	1205	1207	it	it	B-NP	PRP	O	4	SUB	O
O	O	1208	1215	appears	appear	B-VP	VBZ	O	0	ROOT	O
O	O	1216	1220	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	1221	1231	paclitaxel	paclitaxel	B-NP	NN	O	9	NMOD	O
O	O	1232	1235	and	and	O	CC	O	9	NMOD	O
O	O	1236	1241	other	other	B-NP	JJ	O	9	NMOD	O
O	O	1242	1247	drugs	drug	I-NP	NNS	O	14	SUB	O
O	O	1248	1252	that	that	B-NP	WDT	O	9	NMOD	O
O	O	1253	1260	disturb	disturb	B-VP	VBP	O	10	SBAR	O
T26	B-Entity	1261	1272	microtubule	microtubule	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	1273	1281	function	function	I-NP	NN	O	11	OBJ	O
O	O	1282	1286	kill	kill	I-NP	NN	O	5	SBAR	O
O	O	1287	1292	cells	cell	I-NP	NNS	O	14	OBJ	O
O	O	1293	1295	at	at	B-ADVP	IN	O	14	VMOD	O
O	O	1296	1301	least	least	I-ADVP	JJS	O	16	AMOD	O
O	O	1302	1304	in	in	B-PP	IN	O	14	VMOD	O
O	O	1305	1309	part	part	B-NP	NN	O	18	PMOD	O
O	O	1310	1317	through	through	B-PP	IN	O	14	VMOD	O
O	O	1318	1321	the	the	B-NP	DT	O	22	NMOD	O
O	O	1322	1331	induction	induction	I-NP	NN	O	20	PMOD	O
O	O	1332	1334	of	of	B-PP	IN	O	22	NMOD	O
T15	B-Protein	1335	1339	FasL	FasL	B-NP	NN	B-protein	23	PMOD	B-protein
O	O	1339	1340	.	.	O	.	O	4	P	O

O	O	1341	1352	Furthermore	Furthermore	B-ADVP	RB	O	6	VMOD	O
O	O	1352	1353	,	,	O	,	O	6	P	O
T16	B-Protein	1354	1357	Bcl	Bcl	B-NP	NN	B-protein	4	NMOD	B-protein
T16	I-Protein	1357	1358	-	-	O	HYPH	I-protein	6	SUB	I-protein
T16	I-Protein	1358	1359	2	2	B-NP	CD	I-protein	4	NMOD	I-protein
O	O	1360	1371	antagonizes	antagonize	B-VP	VBZ	O	0	ROOT	O
O	O	1372	1376	drug	drug	B-NP	NN	O	10	NMOD	O
O	O	1376	1377	-	-	B-NP	HYPH	O	10	NMOD	O
O	O	1377	1384	induced	induce	I-NP	VBN	O	10	NMOD	O
O	O	1385	1394	apoptosis	apoptosis	I-NP	NN	O	6	OBJ	O
O	O	1395	1397	by	by	B-PP	IN	O	6	VMOD	O
O	O	1398	1408	inhibiting	inhibit	B-VP	VBG	O	11	PMOD	O
O	O	1409	1420	calcineurin	calcineurin	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	1421	1431	activation	activation	I-NP	NN	O	12	OBJ	O
O	O	1431	1432	,	,	O	,	O	12	P	O
O	O	1433	1441	blocking	block	B-VP	VBG	O	12	VMOD	O
O	O	1442	1446	NFAT	NFAT	B-NP	NN	B-protein	19	NMOD	B-protein
O	O	1447	1454	nuclear	nuclear	I-NP	JJ	O	19	NMOD	O
O	O	1455	1468	translocation	translocation	I-NP	NN	O	16	OBJ	O
O	O	1468	1469	,	,	O	,	O	12	P	O
O	O	1470	1473	and	and	O	CC	O	12	VMOD	O
O	O	1474	1484	preventing	prevent	B-VP	VBG	O	12	VMOD	O
T17	B-Protein	1485	1489	FasL	FasL	B-NP	NN	B-protein	24	NMOD	B-protein
O	O	1490	1500	expression	expression	I-NP	NN	O	22	OBJ	O
O	O	1500	1501	.	.	O	.	O	6	P	O

O	O	1502	1505	The	The	B-NP	DT	O	2	NMOD	O
O	O	1506	1513	effects	effect	I-NP	NNS	O	7	SUB	O
O	O	1514	1516	of	of	B-PP	IN	O	2	NMOD	O
T18	B-Protein	1517	1520	Bcl	Bcl	B-NP	NN	B-protein	5	NMOD	B-protein
T18	I-Protein	1520	1521	-	-	O	HYPH	I-protein	3	PMOD	I-protein
T18	I-Protein	1521	1522	2	2	B-NP	CD	I-protein	5	NMOD	I-protein
O	O	1523	1526	can	can	B-VP	MD	O	0	ROOT	O
O	O	1527	1529	be	be	I-VP	VB	O	7	VC	O
O	O	1530	1538	overcome	overcome	I-VP	VBN	O	8	VC	O
O	O	1538	1539	,	,	O	,	O	9	P	O
O	O	1540	1542	at	at	B-ADVP	IN	O	9	VMOD	O
O	O	1543	1548	least	least	I-ADVP	JJS	O	11	AMOD	O
O	O	1549	1558	partially	partially	B-ADVP	RB	O	9	VMOD	O
O	O	1558	1559	,	,	O	,	O	9	P	O
O	O	1560	1567	through	through	B-PP	IN	O	9	VMOD	O
O	O	1568	1583	phosphorylation	phosphorylation	B-NP	NN	O	15	PMOD	O
O	O	1584	1586	of	of	B-PP	IN	O	16	NMOD	O
T19	B-Protein	1587	1590	Bcl	Bcl	B-NP	NN	B-protein	19	NMOD	B-protein
T19	I-Protein	1590	1591	-	-	B-NP	HYPH	I-protein	17	PMOD	I-protein
T19	I-Protein	1591	1592	2	2	I-NP	CD	I-protein	19	NMOD	I-protein
O	O	1592	1593	.	.	O	.	O	7	P	O

O	O	1594	1608	Phosphorylated	Phosphorylate	B-NP	VBN	O	18	VMOD	O
T20	B-Protein	1609	1612	Bcl	Bcl	I-NP	NN	B-protein	3	NMOD	B-protein
T20	I-Protein	1612	1613	-	-	O	HYPH	I-protein	1	P	I-protein
T20	I-Protein	1613	1614	2	2	B-NP	CD	I-protein	1	NMOD	I-protein
O	O	1615	1621	cannot	cannot	B-VP	MD	O	1	VMOD	O
O	O	1622	1626	bind	bind	I-VP	VB	O	5	VC	O
T21	B-Protein	1627	1638	calcineurin	calcineurin	B-NP	NN	B-protein	6	OBJ	B-protein
O	O	1638	1639	,	,	O	,	O	18	P	O
O	O	1640	1643	and	and	O	CC	O	18	VMOD	O
O	O	1644	1648	NFAT	NFAT	B-NP	NN	B-protein	11	NMOD	B-protein
O	O	1649	1659	activation	activation	I-NP	NN	O	17	NMOD	O
O	O	1659	1660	,	,	O	,	O	17	P	O
T22	B-Protein	1661	1665	FasL	FasL	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	1666	1676	expression	expression	I-NP	NN	O	17	NMOD	O
O	O	1676	1677	,	,	O	,	O	17	P	O
O	O	1678	1681	and	and	O	CC	O	17	NMOD	O
O	O	1682	1691	apoptosis	apoptosis	B-NP	NN	O	18	SUB	O
O	O	1692	1695	can	can	B-VP	MD	O	0	ROOT	O
O	O	1696	1701	occur	occur	I-VP	VB	O	18	VC	O
O	O	1702	1707	after	after	B-PP	IN	O	19	VMOD	O
T23	B-Protein	1708	1711	Bcl	Bcl	B-NP	NN	B-protein	24	NMOD	B-protein
T23	I-Protein	1711	1712	-	-	O	HYPH	I-protein	24	NMOD	I-protein
T23	I-Protein	1712	1713	2	2	B-NP	CD	I-protein	24	NMOD	I-protein
O	O	1714	1729	phosphorylation	phosphorylation	I-NP	NN	O	20	PMOD	O
O	O	1729	1730	.	.	O	.	O	18	P	O
